A Phase 1B Clinical Trial of BKM120 with Bortezomib in Defned Genetic Subgroups of Patients with Relapsed or Refractory Multiple Myeloma

  • Fenwick, Nicola (Principal Investigator)

Project Details

Short titleA Phase 1B Clinical Trial of BKM120 with Bortezomib in Defned Genetic Subgroups of Patients with Relapsed or Refractory Multiple Myeloma
StatusFinished
Effective start/end date9/11/15 → 1/01/23

Funding

  • NOVARTIS PHARMACEUTICALS UK LTD
  • Janssen-Cilag Limited